SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 129 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $346,000 | +81.2% | 35,400 | +100.0% | 0.00% | -20.0% |
| Q4 2016 | $191,000 | +5.5% | 17,700 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $181,000 | -21.6% | 17,700 | 0.0% | 0.01% | -16.7% |
| Q2 2016 | $231,000 | -40.8% | 17,700 | -50.0% | 0.01% | +20.0% |
| Q1 2016 | $390,000 | +139.3% | 35,400 | +100.0% | 0.01% | +25.0% |
| Q4 2015 | $163,000 | +32.5% | 17,700 | 0.0% | 0.00% | +33.3% |
| Q3 2015 | $123,000 | -29.3% | 17,700 | 0.0% | 0.00% | -40.0% |
| Q2 2015 | $174,000 | +10.8% | 17,700 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $157,000 | +1.3% | 17,700 | 0.0% | 0.00% | +33.3% |
| Q4 2014 | $155,000 | +27.0% | 17,700 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $122,000 | +31.2% | 17,700 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $93,000 | +14.8% | 17,700 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $81,000 | -9.0% | 17,700 | 0.0% | 0.00% | -25.0% |
| Q4 2013 | $89,000 | -1.1% | 17,700 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $90,000 | +2.3% | 17,700 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $88,000 | – | 17,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
| Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
| Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
| MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
| Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
| TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
| Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
| GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
| Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |